{"article_title": "Ex-Glaxo Executive Mark Reilly Is at Center of Investigation in China", "article_keywords": ["seized", "center", "exglaxo", "wasnt", "executive", "vacation", "visits", "mark", "investigation", "china", "uk", "detained", "reilly", "officials", "weeksweeks"], "article_url": "http://www.wsj.com/articles/SB10001424052702304547704579561973142201850", "article_text": "Last July, U.K. national Mark Reilly, a career man at drug maker GlaxoSmithKline PLC who had risen up the ranks to head its China operations, returned to his home country on a planned vacation for a few weeks.\n\nWeeks earlier, several of Glaxo's offices in China had been raided by law-enforcement officials who had seized documents and detained some employees. Mr. Reilly wasn't detained, although he knew about the visits, according to a person familiar with the matter. Officials publicly accused Glaxo of corruption the same...", "article_metadata": {"article.template": "snippet", "article.created": "2014-05-14T20:57:00.000Z", "article.section": "Business", "page.region": "na,us", "page.content.type": "Article", "twitter": {"domain": "wsj.com", "description": "Mark Reilly, who built his career at drug maker GlaxoSmithKline, is at the center of a huge investigation after China accused him of orchestrating whole departments of Glaxo staff to bribe doctors and health-care organizations.", "creator": "@hesterplumridge", "image": {"alt": "Mark Reilly, a career man at drug maker GlaxoSmithKline, is now at the center of an investigation in China", "identifier": "http://si.wsj.net/img/WSJ_Logo_black_social.gif"}, "title": "Ex-Glaxo Executive Mark Reilly Is at Center of Investigation in China", "site": "@WSJ", "card": "summary"}, "al": {"ios": {"url": "wsj://launch?articleid=SB10001424052702304547704579561973142201850&headline=Mark%20Reilly%2C%20a%20career%20man%20at%20drug%20maker%20GlaxoSmithKline%2C%20is%20now%20at%20the%20center%20of%20an%20investigation%20in%20China&weburl=http://www.wsj.com/articles/SB10001424052702304547704579561973142201850"}}, "page.site.product": "WSJ", "keywords": "glaxo bribery probe,glaxo china,GlaxoSmithKline,GSK.LN,GSK.US:NYSE,Mark Reilly,corporate crime,legal action,corporate,industrial news,bribery,political,general news,corruption,crime,courts,financial crime,pharmaceuticals,health care,life sciences", "news_keywords": "glaxo bribery probe,glaxo china,GlaxoSmithKline,GSK.LN,GSK.US:NYSE,Mark Reilly,corporate crime,legal action,corporate,industrial news", "article.headline": "Mark Reilly, a career man at drug maker GlaxoSmithKline, is now at the center of an investigation in China", "description": "Mark Reilly, who built his career at drug maker GlaxoSmithKline, is at the center of a huge investigation after China accused him of orchestrating whole departments of Glaxo staff to bribe doctors and health-care organizations.", "apple-itunes-app": "app-id=364387007,app-argument=wsj://launch?articleid=SB10001424052702304547704579561973142201850&headline=Mark%20Reilly%2C%20a%20career%20man%20at%20drug%20maker%20GlaxoSmithKline%2C%20is%20now%20at%20the%20center%20of%20an%20investigation%20in%20China&weburl=http://www.wsj.com/articles/SB10001424052702304547704579561973142201850", "user.type": "nonsubscriber", "article.page": "Business", "page.content.format": "responsive", "article.summary": "Mark Reilly, who built his career at drug maker GlaxoSmithKline, is at the center of a huge investigation after China accused him of orchestrating whole departments of Glaxo staff to bribe doctors and health-care organizations.", "page.site": "wsj", "testkeys": "A", "article.published": "2014-05-14T20:57:00.000Z", "dj.asn": "i-6fe6", "robots": "noarchive,noodp", "fb": {"app_id": 368513495882}, "article": {"internal_link_count": 6, "word_count": 528, "publisher": "https://www.facebook.com/wsj"}, "viewport": "width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=1.0, user-scalable=no", "page.section": "Article", "language": "en-US", "og": {"site_name": "WSJ", "description": "Mark Reilly, who built his career at drug maker GlaxoSmithKline, is at the center of a huge investigation after China accused him of orchestrating whole departments of Glaxo staff to bribe doctors and health-care organizations.", "title": "Ex-Glaxo Executive Mark Reilly Is at Center of Investigation in China", "url": "http://www.wsj.com/articles/SB10001424052702304547704579561973142201850", "image": {"width": 1200, "identifier": "http://si.wsj.net/img/WSJ_Logo_black_social.gif", "height": 630}, "locale": "en_US", "type": "article"}, "author": "Hester Plumridge, Christopher M. Matthews and Laurie Burkitt", "article.access": "paid", "page.content.source": "WSJ Online Article", "article.origheadline": "Ex-Glaxo Executive Mark Reilly Is at Center of Investigation in China", "article.type": "Business", "article.id": "SB10001424052702304547704579561973142201850", "user.exp": "default", "article.updated": "2014-05-14T20:57:00.000Z"}, "article_summary": "Mr. Reilly wasn't detained, although he knew about the visits, according to a person familiar with the matter.\nWeeks earlier, several of Glaxo's offices in China had been raided by law-enforcement officials who had seized documents and detained some employees.\nLast July, U.K. national Mark Reilly, a career man at drug maker GlaxoSmithKline PLC who had risen up the ranks to head its China operations, returned to his home country on a planned vacation for a few weeks.\nOfficials publicly accused Glaxo of corruption the same..."}